Percutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations

Table 3

Characteristics of monocyte subsets defined by expression of CD14 and CD16 in samples from PAD patients before and after PTA.

	CD14++CD16− (classical) %	CD14++CD16+ (intermediate) %	CD14+CD16++ (nonclassical) %
Before PTA (Sample 0)	76.9 ± 7.9	10.2 ± 3.7	10.5 ± 4.9
After PTA (Sample 1)	77.7 ± 7.9	9.9 ± 4.3	10.0 ± 4.6